Ribavirin - current status of a broad spectrum antiviral agent
- 1 August 2001
- journal article
- review article
- Published by Informa UK Limited in Expert Opinion on Pharmacotherapy
- Vol. 2 (8), 1317-1324
- https://doi.org/10.1517/14656566.2.8.1317
Abstract
Ribavirin is a very broad-spectrum virustatic antiviral agent, first synthesised in 1972. It is characterised by low toxicity apart from reversible anaemia, usually mild. Its multiple mechanisms of action mean that viral resistance rarely develops. It can be administered orally, intravenously, or via a nebuliser. It has shown varying degrees of clinical efficacy in a variety of human diseases including respiratory tract infections due to respiratory syncytial virus and influenza, measles, herpesvirus infections, HIV infection, Lassa fever, haemorrhagic fever with renal syndrome, and (in combination with IFN-α) chronic hepatitis C infection. It may well prove of value against other emerging exotic infections (e.g., West Nile virus, Nipah virus).Keywords
This publication has 48 references indexed in Scilit:
- Hantavirus Pulmonary Syndrome in the Americas: The Early YearsSeminars in Respiratory and Critical Care Medicine, 2000
- Drug Sensitivity of Human Immunodeficiency Virus Type 1 Isolates after Ribavirin TherapyThe Journal of Infectious Diseases, 1997
- High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infectionThe Journal of Pediatrics, 1994
- Severe Measles Pneumonitis in Adults: Evaluation of Clinical Characteristics and Therapy with Intravenous RibavirinClinical Infectious Diseases, 1994
- In vitro and in vivo effects of ribavirin on human respiratory epithelium.Thorax, 1990
- Lassa FeverNew England Journal of Medicine, 1986
- Virazole and adjuvant‐induced disease in ratsArthritis & Rheumatism, 1977
- IMMUNOSUPPRESSIVE ACTIVITY OF RIBAVIRIN USING THE RABBIT SKIN ALLOGRAFT MODELAnnals of the New York Academy of Sciences, 1977
- Treatment of chronic hepatitis B virus infection with rebavrin.BMJ, 1977
- Ribavirin: Efficacy in the Treatment of Murine Autoimmune DiseaseScience, 1977